Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 May;59(5):802-9.
doi: 10.1172/JCI108702.

Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro

Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro

J E Repine et al. J Clin Invest. 1977 May.

Abstract

Serum from three patients with a complete, selective deficiency of the second component of complement (C2) did not promote optimal killing of Staphylococcus aureus, 502A by neutrophilic polymorphonuclear leukocytes (PMN) in vitro. The addition of C2 reagent or the presence of heat-stable opsonin in the C2-deficient serum corrected the defective killing of S. aureus that was observed with patient or control PMN. PMN from the patients or control subjects killed bacteria with equal efficiency under conditions of optimal opsonization (normal pooled serum). However, twice-washed control PMN were better than patient PMN in killing S. aureus under circumstances of suboptimal opsonization (C2-deficient serum, heated C2-deficient serum, heated normal pooled serum, or no replacement of serum). The latter finding was due to residual C2 on the surface of twice-washed control cells. As repeated washing of control PMN progressively removed cell-associated C2, the staphylocidal effectiveness of the control RMN decreased to the level of patient PMN. In contrast to the findings with S. aureus, triply-washed PMN from patients or controls killed normal numbers of Escherichia coli, ON2, in C2-deficient serum.

PubMed Disclaimer

References

    1. Ann Intern Med. 1975 Mar;82(3):323-28 - PubMed
    1. J Immunol. 1977 Jan;118(1):362-8 - PubMed
    1. J Lab Clin Med. 1976 Aug;88(2):316-27 - PubMed
    1. J Clin Invest. 1976 Oct;58(4):853-61 - PubMed
    1. Ann Intern Med. 1975 Dec;83(6):813-6 - PubMed

Publication types